[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:stil-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"STIL Gene",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06353997","Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II\u002FIII TNBC Patients",[11],"Phase 2","RECRUITING","2026-08-26T02:16:20.336282Z","2026-05-05T02:43:27.595158Z"]